THERALLO Trademark
Trademark Overview
On Friday, October 31, 2025, a trademark application was filed for THERALLO with the United States Patent and Trademark Office. The USPTO has given the THERALLO trademark a serial number of 99472514. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2026. This trademark is owned by THERALLO. The THERALLO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatories; Pharmaceutical preparations for activating cell function for medical purposes; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Biochemical reagents for medical or veterinary purposes; Biological tissue cultures for medical purposes; Stem cells for medical purposes; Cell culture media for medical purposes
Research and development in the field of allogeneic and autologous molecular and cell therapies; Scientific and technological services, namely, research and design in the field of allogeneic and autologous molecular and cell therapies; Medical research services; Pharmaceutical research services; Research and development in the field of stem cells, cell and gene therapy and biotechnology; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing scientific research information in the field of stem cells, cell and gene therapy and biotechnology; Scientific study and research in the field(s) of molecular and allogeneic or autologous cell therapy; Providing medical and scientific research information
General Information
| Serial Number | 99472514 |
| Word Mark | THERALLO |
| Filing Date | Friday, October 31, 2025 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 2, 2026 |
| Registration Number | 8282142 |
| Registration Date | Tuesday, June 2, 2026 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 14, 2026 |
Trademark Statements
| Goods and Services | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatories; Pharmaceutical preparations for activating cell function for medical purposes; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Biochemical reagents for medical or veterinary purposes; Biological tissue cultures for medical purposes; Stem cells for medical purposes; Cell culture media for medical purposes |
| Goods and Services | Research and development in the field of allogeneic and autologous molecular and cell therapies; Scientific and technological services, namely, research and design in the field of allogeneic and autologous molecular and cell therapies; Medical research services; Pharmaceutical research services; Research and development in the field of stem cells, cell and gene therapy and biotechnology; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing scientific research information in the field of stem cells, cell and gene therapy and biotechnology; Scientific study and research in the field(s) of molecular and allogeneic or autologous cell therapy; Providing medical and scientific research information |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 31, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 31, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | THERALLO |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 92 - NOT AVAILABLE |
| Address | Nice 06000
FR |
| Party Name | THERALLO |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 92 - NOT AVAILABLE |
| Address | Nice 06000
FR |
| Party Name | THERALLO |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 92 - NOT AVAILABLE |
| Address | Nice 06000
FR |
Trademark Events
| Event Date | Event Description |
| Friday, October 31, 2025 | NEW APPLICATION ENTERED |
| Friday, October 31, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, February 11, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 16, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, March 18, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 8, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 14, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 14, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, April 24, 2026 | ASSIGNED TO EXAMINER |
| Tuesday, June 2, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 2, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
